Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 0.4509 | 1 |
Giardia lamblia | Kinase, PLK | 0.0092 | 0.4509 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 0.4509 | 1 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0092 | 0.4509 | 1 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0092 | 0.4509 | 0.4348 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0041 | 0.0663 | 0.0896 |
Mycobacterium leprae | possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). | 0.0032 | 0.0003 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 0.4509 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 0.4509 | 1 |
Mycobacterium ulcerans | extragenic suppressor protein SuhB | 0.0036 | 0.0285 | 0.5 |
Echinococcus multilocularis | chromobox protein 1 | 0.0073 | 0.307 | 0.2867 |
Brugia malayi | chromobox protein homolog 3 | 0.0041 | 0.0663 | 0.0896 |
Echinococcus granulosus | chromobox protein 1 | 0.0073 | 0.307 | 0.2867 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 0.4509 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 0.4509 | 1 |
Loa Loa (eye worm) | inositol-1 | 0.0036 | 0.0285 | 0.0631 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0044 | 0.0896 | 0.1988 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0092 | 0.4509 | 1 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0036 | 0.0285 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0045 | 0.1017 | 0.1733 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0092 | 0.4509 | 1 |
Brugia malayi | Heterochromatin protein 1 | 0.0073 | 0.307 | 0.6593 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0092 | 0.4509 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0092 | 0.4509 | 0.4348 |
Trypanosoma brucei | polo-like protein kinase | 0.0092 | 0.4509 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0092 | 0.4509 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0041 | 0.0663 | 0.0896 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0041 | 0.0663 | 0.1471 |
Schistosoma mansoni | chromobox protein | 0.0073 | 0.307 | 0.2867 |
Trichomonas vaginalis | chromobox protein, putative | 0.0073 | 0.307 | 0.6593 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0663 | 0.1471 |
Mycobacterium tuberculosis | Inositol-1-monophosphatase SuhB | 0.0032 | 0.0003 | 0.5 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0092 | 0.4509 | 0.4348 |
Trichomonas vaginalis | chromobox protein, putative | 0.0044 | 0.0896 | 0.1448 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.0073 | 0.307 | 0.6808 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0092 | 0.4509 | 1 |
Echinococcus granulosus | chromobox protein 1 | 0.0073 | 0.307 | 0.2867 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0092 | 0.4509 | 1 |
Trichomonas vaginalis | chromobox protein, putative | 0.0073 | 0.307 | 0.6593 |
Echinococcus multilocularis | chromobox protein 1 | 0.0073 | 0.307 | 0.2867 |
Toxoplasma gondii | inositol(myo)-1(or 4)-monophosphatase 2, putative | 0.0036 | 0.0285 | 0.5 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0092 | 0.4509 | 1 |
Schistosoma mansoni | chromobox protein | 0.0073 | 0.307 | 0.2867 |
Trichomonas vaginalis | chromobox protein, putative | 0.0044 | 0.0896 | 0.1448 |
Schistosoma mansoni | kinase | 0.0047 | 0.1108 | 0.0848 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0045 | 0.1017 | 0.1733 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.